Reagents for Glucagon and Incretin Research (R43/R44)
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of: A) Validated, highly sensitive, and specific assays for plasma glucagon B) Reagents for manipulation of glucagon receptor activity in the pancreatic islet and other tissues C) Reagents to be used to improve our understanding of pancreatic alpha-cell biology particularly in response to glucagon and incretins D) Reagents and assays for the accurate expression and quantitation of functional incretin receptors in the endocrine/exocrine cells of the pancreas and relevant extrapancreatic tissues.
General information about this opportunity
Last Known Status
Deleted 12/25/2014 (Archived.)
Program Number
RFA-DK-14-008 Federal Agency/Office
Agency: Department of Health and Human ServicesOffice: National Institutes of Health
Type(s) of Assistance Offered
Grant Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. What is the process for applying and being award this assistance?
Deadlines
11/24/2014 Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements. Who do I contact about this opportunity?
Headquarters Office
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Website Address
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-008.html
E-mail Address
FBOWebmaster@OD.NIH.GOV
Financial Information
Obligations
$2,000,000.00
